Loading clinical trials...
Loading clinical trials...
Randomized, Controlled, Multicenter, Double-Masked, Parallel, Phase 3 Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis
Conditions
Interventions
TP-03
TP-03 Vehicle
Locations
21
United States
Global Retina Institute
Scottsdale, Arizona, United States
Shultz Chang Vision
Northridge, California, United States
East Bay Eye Center
San Ramon, California, United States
Vision Institute
Colorado Springs, Colorado, United States
Pinnacle Research Institute
Fort Lauderdale, Florida, United States
Jackson Eye, S.C.
Lake Villa, Illinois, United States
Start Date
April 29, 2021
Primary Completion Date
May 9, 2022
Completion Date
May 9, 2022
Last Updated
December 21, 2023
NCT04603222
NCT07451678
NCT06235450
NCT05062564
NCT05160623
NCT03301844
Lead Sponsor
Tarsus Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions